tyramine has been researched along with clozapine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Dill, RE; Dorris, RL; Phillips-Thonnard, I | 1 |
| Bugatti, A; Cattabeni, F; Di Giulio, AM; Galli, CL; Groppetti, A; Parenti, M; Racagni, G | 1 |
| Cattabeni, F; Galli, CL; Groppetti, A; Racagni, G | 1 |
| Buus Lassen, J | 1 |
| Lassen, JB | 1 |
| Faivre, F; Reveley, A; Taylor, D | 1 |
| Fu, D; Javitch, JA; Lin, H; Strange, PG; Wilson, J | 1 |
2 review(s) available for tyramine and clozapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Significance of neurochemical parameters in the preclinical evaluation of neuroleptic drugs.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain Chemistry; Clozapine; Corpus Striatum; Dopamine; Drug Evaluation, Preclinical; gamma-Aminobutyric Acid; Haloperidol; Neural Pathways; Neurons; Parasympathetic Nervous System; Postmortem Changes; Substantia Nigra; Tyramine | 1979 |
7 other study(ies) available for tyramine and clozapine
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
A pharmacologic model of Huntington's chorea.
Topics: Animals; Carbachol; Catheterization; Clozapine; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Huntington Disease; Hydrazines; Levodopa; Male; Phentolamine; Rats; Trifluoperazine; Tyramine | 1976 |
3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Haloperidol; Homovanillic Acid; Kainic Acid; Male; Phenylacetates; Rats; Tyramine | 1978 |
Inhibition of 4,alpha-dimethyl-m-tyramine (H 77/77)-induced hypermotility in rats by single and repeated administration of chloropromazine, haloperidol, clozapine and thioridazine.
Topics: Adrenergic Agents; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Haloperidol; Motor Activity; Rats; Thioridazine; Tyramine | 1975 |
Evidence for a noradrenergic mechanism in the grooming produced by (+)-amphetamine and 4, alpha-dimethyl-m-tyramine (H 77/77) in rats.
Topics: Amphetamine; Animals; Butyrophenones; Clozapine; Diazepam; Diphenhydramine; Grooming; Haloperidol; Male; Norepinephrine; Phenothiazines; Rats; Tyramine | 1977 |
Clozapine-induced hypotension treated with moclobemide and Bovril.
Topics: Adult; Antipsychotic Agents; Benzamides; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypotension, Orthostatic; Male; Moclobemide; Monoamine Oxidase Inhibitors; Schizophrenia; Schizophrenic Psychology; Tyramine | 1995 |
Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
Topics: 1-Methyl-3-isobutylxanthine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Binding, Competitive; Bromocriptine; Butaclamol; Chlorpromazine; CHO Cells; Clozapine; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; GTP-Binding Proteins; Haloperidol; Humans; Macromolecular Substances; Mutagenesis, Site-Directed; Phenethylamines; Piperidines; Protein Binding; Protein Conformation; Radioligand Assay; Receptors, Dopamine D2; Recombinant Fusion Proteins; Sodium; Spiperone; Structure-Activity Relationship; Sulpiride; Transfection; Tyramine | 2001 |